Innate Pharma S.A.

NASDAQ: IPHA · Real-Time Price · USD
2.11
-0.07 (-3.21%)
At close: Aug 15, 2025, 3:59 PM
2.12
0.47%
After-hours: Aug 15, 2025, 04:00 PM EDT

Innate Pharma S.A. Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-49.47M -7.57M -58.1M -52.81M
Depreciation & Amortization
1.99M 5.09M 45.41M 4.6M
Stock-Based Compensation
3.94M 4.26M 4.25M 2.62M
Other Working Capital
39.16M -28.2M -636K -6.06M
Other Non-Cash Items
-2.52M -2.24M 1.8M -1.29M
Deferred Income Tax
n/a n/a n/a -1.68M
Change in Working Capital
39.16M -32.09M -12.5M -9.88M
Operating Cash Flow
-6.9M -32.56M -19.15M -58.46M
Capital Expenditures
-391K -2.35M -1.12M -1.33M
Cash Acquisitions
n/a n/a n/a 7K
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
9.59M 22.77M 3M n/a
Other Investing Acitivies
1K -1.79M -1K 406K
Investing Cash Flow
9.2M 20.63M 1.88M -917K
Debt Repayment
-8.94M -2.36M -2.03M 26.63M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
2.93M 395K n/a 188K
Financial Cash Flow
-6.01M -1.97M -1.83M 26.82M
Net Cash Flow
-4.21M -13.62M -19.53M -33.04M
Free Cash Flow
-7.29M -34.91M -20.28M -59.79M